HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Boccardo Selected Research

Androgens

10/2018FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist.
10/2017Targeting androgen-independent pathways: new chances for patients with prostate cancer?
8/2000Hormone therapy of prostate cancer: is there a role for antiandrogen monotherapy?
2/2000Comparison of an LH-RH analogue (Goeserelin acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: final survival results of an international multicentre randomized-trial. International Prostate Cancer Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Boccardo Research Topics

Disease

13Breast Neoplasms (Breast Cancer)
02/2016 - 07/2000
11Prostatic Neoplasms (Prostate Cancer)
10/2018 - 02/2000
9Lymphedema (Milroy Disease)
12/2015 - 01/2001
7Neoplasms (Cancer)
01/2019 - 09/2000
3Cysts
01/2019 - 07/2001
3Endometrial Neoplasms (Endometrial Cancer)
05/2013 - 05/2004
2Chylous Ascites
01/2019 - 01/2016
2Carcinogenesis
02/2016 - 08/2014
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2012 - 05/2006
2Gynecomastia
04/2006 - 02/2005
2Carcinoma (Carcinomatosis)
01/2006 - 01/2003
2Neutropenia
01/2006 - 05/2004
2Breast Cancer Lymphedema
01/2006 - 09/2002
1Lymphocele
01/2019
1Wounds and Injuries (Trauma)
01/2019
1Ascites
01/2016
1Malignant Mesothelioma
08/2014
1Bone Fractures (Bone Fracture)
05/2013
1Melanoma (Melanoma, Malignant)
03/2013
1Pleural Effusion (Pleural Effusions)
09/2012
1Common Variable Immunodeficiency
06/2012
1Thrombocytopenia (Thrombopenia)
03/2012
1Glycogen Storage Disease Type VI (Glycogenosis Type VI)
05/2006
1Neoplasm Metastasis (Metastasis)
05/2006
1Anemia
01/2006
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2006
1Cough
09/2005
1Mastodynia
02/2005
1Fever (Fevers)
05/2004
1Kidney Neoplasms (Kidney Cancer)
01/2003
1Urologic Neoplasms (Urological Cancer)
01/2003
1Wilms Tumor (Wilm's Tumor)
01/2003
1Edema (Dropsy)
09/2002
1Infections
09/2002
1Ovarian Neoplasms (Ovarian Cancer)
07/2001
1Stomatitis
01/2001

Drug/Important Bio-Agent (IBA)

8TamoxifenFDA LinkGeneric
05/2013 - 07/2000
5Cisplatin (Platino)FDA LinkGeneric
03/2012 - 01/2001
4AndrogensIBA
10/2018 - 02/2000
4Anastrozole (Arimidex)FDA LinkGeneric
05/2013 - 02/2005
4Hormones (Hormone)IBA
02/2005 - 08/2000
3Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2018 - 02/2000
3Proteins (Proteins, Gene)FDA Link
02/2016 - 09/2000
3bicalutamide (Casodex)FDA LinkGeneric
04/2006 - 02/2005
3Paclitaxel (Taxol)FDA LinkGeneric
01/2006 - 01/2001
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2004 - 07/2000
2Octreotide (Sandostatin)FDA LinkGeneric
01/2019 - 01/2016
2IfosfamideFDA LinkGeneric
01/2003 - 01/2001
2Peptides (Polypeptides)IBA
01/2001 - 09/2000
2Androgen Antagonists (Antiandrogens)IBA
08/2000 - 02/2000
1sulfan blue (patent blue V)IBA
01/2019
1Testosterone (Sustanon)FDA Link
10/2018
1PeriostinIBA
02/2016
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
01/2016
1AsbestosIBA
08/2014
1MicroRNAs (MicroRNA)IBA
08/2014
1Triglycerides (Triacylglycerol)IBA
09/2012
1Immunoglobulins (Immunoglobulin)IBA
06/2012
1GemcitabineFDA Link
03/2012
1Heterogeneous-Nuclear Ribonucleoprotein KIBA
05/2009
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
05/2009
1Carrier Proteins (Binding Protein)IBA
04/2006
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2006
1Insulin-Like PeptidesIBA
04/2006
1Insulin-Like Growth Factor Binding ProteinsIBA
04/2006
1CollagenIBA
11/2005
1imidazole mustard (BIC)IBA
11/2005
1Dihydrotestosterone (Androstanolone)IBA
11/2005
1Oxygen (Dioxygen)IBA
09/2005
1Prostate-Specific Antigen (Semenogelase)IBA
02/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2004
1PlatinumIBA
05/2004
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
05/2004
1Indicators and Reagents (Reagents)IBA
01/2004
12,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA
01/2004
1LignansIBA
01/2004
1Aminoglutethimide (Cytadren)FDA Link
11/2001
1Aromatase InhibitorsIBA
11/2001
1Epidermal Growth Factor (EGF)IBA
07/2001
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2001
1Estrogen Receptor Modulators (Antiestrogen)IBA
01/2001
1ProlactinIBA
01/2001
1Epirubicin (Ellence)FDA LinkGeneric
01/2001

Therapy/Procedure

13Therapeutics
10/2017 - 08/2000
7Drug Therapy (Chemotherapy)
03/2012 - 07/2000
4Adjuvant Chemotherapy
01/2019 - 01/2001
4Radiotherapy
01/2006 - 09/2002
3Lymph Node Excision (Lymph Node Dissection)
01/2019 - 01/2006
2Conservative Treatment
01/2019 - 12/2013
2Castration
10/2017 - 01/2016
2Cystectomy
03/2012 - 05/2006
2Manual Lymphatic Drainage
09/2002 - 09/2002
1Length of Stay
01/2019
1Nephrectomy
01/2019
1Total Parenteral Nutrition
01/2019
1Operative Time
01/2019
1Immunotherapy
10/2017
1Induced Hyperthermia (Thermotherapy)
09/2002
1Physical Therapy Modalities (Physical Therapy Technique)
09/2002